BIOTON's earnings have been declining at an average annual rate of -60.5%, while the Biotechs industry saw earnings growing at 17% annually. Revenues have been growing at an average rate of 6.3% per year. BIOTON's return on equity is 0.7%, and it has net margins of 1.5%.
How BIOTON makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
WSE:BIO Revenue, expenses and earnings (PLN Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
266
4
75
4
31 Dec 25
283
3
73
4
30 Sep 25
296
-3
71
4
30 Jun 25
265
-10
68
4
31 Mar 25
236
-16
69
4
31 Dec 24
208
-16
67
4
30 Sep 24
178
-6
70
4
30 Jun 24
186
-7
73
5
31 Mar 24
185
-3
71
5
31 Dec 23
182
2
71
6
30 Sep 23
212
2
70
5
30 Jun 23
218
4
67
6
31 Mar 23
217
4
67
6
31 Dec 22
233
1
65
5
30 Sep 22
197
-4
63
5
30 Jun 22
188
3
60
5
31 Mar 22
176
5
60
4
31 Dec 21
163
3
60
5
30 Sep 21
212
22
63
5
30 Jun 21
208
20
67
5
31 Mar 21
222
23
74
5
31 Dec 20
222
34
74
4
30 Sep 20
185
-24
89
6
30 Jun 20
186
-34
94
6
31 Mar 20
208
-148
97
6
31 Dec 19
202
-127
108
7
30 Sep 19
209
-98
108
17
30 Jun 19
213
-109
110
23
31 Mar 19
226
76
125
24
31 Dec 18
241
26
134
33
30 Sep 18
294
29
145
38
30 Jun 18
337
47
161
33
31 Mar 18
338
-39
157
33
31 Dec 17
362
-27
157
25
30 Sep 17
303
-31
152
8
30 Jun 17
286
-31
149
8
31 Mar 17
279
-28
150
7
31 Dec 16
278
-16
146
8
30 Sep 16
251
-536
143
7
30 Jun 16
289
-526
140
6
31 Mar 16
308
-522
138
5
31 Dec 15
333
-522
136
4
30 Sep 15
417
14
142
3
30 Jun 15
411
10
142
3
Quality Earnings: BIO has high quality earnings.
Growing Profit Margin: BIO became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BIO has become profitable over the past 5 years, growing earnings by -60.5% per year.
Accelerating Growth: BIO has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: BIO has become profitable in the last year, making it difficult to compare its past year earnings growth to the Biotechs industry (7.2%).
Return on Equity
High ROE: BIO's Return on Equity (0.7%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/19 17:40
End of Day Share Price
2026/06/19 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BIOTON S.A. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.